Cargando…
Perking Up Strategies to Control Restenosis
[Figure: see text]
Autor principal: | Riascos-Bernal, Dario F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091502/ https://www.ncbi.nlm.nih.gov/pubmed/32215377 http://dx.doi.org/10.1016/j.jacbts.2020.01.013 |
Ejemplares similares
-
In-Stent Restenosis: Chasing Our Tails in Search of a Solution
por: Lahmann, Anna Lena, et al.
Publicado: (2020) -
PERK Inhibition Mitigates Restenosis and Thrombosis: A Potential Low-Thrombogenic Antirestenotic Paradigm
por: Wang, Bowen, et al.
Publicado: (2020) -
How PERK kinase conveys stress signals to nuclear factor-κB to mediate estrogen-induced apoptosis in breast cancer cells?
por: Fan, Ping, et al.
Publicado: (2018) -
The impact of cytochrome P 450 2 C19 polymorphism on the occurrence of 1-year in-stent restenosis in patients who underwent percutaneous coronary intervention: A case-match study
por: Kracskó, Bertalan
Publicado: (2015) -
T cell-oriented strategies for controlling the COVID-19 pandemic
por: Noh, Ji Yun, et al.
Publicado: (2021)